(MedPage Today) -- Patients with rheumatoid arthritis treated with the interleukin-6 receptor blocker tocilizumab (Actemra) experienced the expected increases in lipids, but also had favorable alterations in certain types of lipid particles, researchers found. via MedPageToday.com - medical news plus CME for physicians Read More Here..
Lake forest health and fitness http://healthandfitness1blog.blogspot.com/2013/12/actemra-may-have-lipid-benefits-cmece.html
No comments:
Post a Comment